Clinical Trials Logo

Pruritus clinical trials

View clinical trials related to Pruritus.

Filter by:

NCT ID: NCT04256759 Recruiting - Pruritus Clinical Trials

Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

Start date: September 1, 2020
Phase: Phase 2
Study type: Interventional

To investigate the potential efficacy of dupilumab in the treatment of moderate to severe chronic hepatic pruritus.

NCT ID: NCT04160598 Recruiting - Clinical trials for Magnesium Infusion in Post-spinal Opioid Pruritis

Effect of Intravenous Magnesium on Post-spinal Fentanyl Induced Pruritus Incidence

Start date: September 2, 2020
Phase: N/A
Study type: Interventional

Introduction: Adding opioids to local anesthetic solutions leads to enhanced anesthesia and provide postoperative analgesia. Intrathecaly injected opioids have some side effects, though. One of them is pruritus. Objective: We designed a randomized, double-blinded, placebo-controlled study to evaluate prophylactic impact of continuous IV Magnesium 10mg/kg over 30 minutes on intrathecal fentanyl-induced pruritus start at the end of the operation. Methods: ASA I-II Patient's candidate for orthopedic operations under spinal anesthesia (10-15mg hyperbaric bupivacaine and 25 µg fentanyl intrathecal) and will be divided randomly into two groups: Control group (Placebo group): bolus 100 ml nacl 0.9% at end of surgery Study group (Mg ++ group): (continuous IV Magnesium 10mg/kg in 100 ml Nacl0.9% over 30 minutes at end of surgery). Study outcome: 1. Hemodynamics: Systolic blood pressure, Mean arterial blood pressure, pulse rate, O2 saturation will be recorded in 5 min,10 min,30 min,60 min and every one hour till 6 hours after the operation. 2. Pruritus Patients were asked about existence (present=1,no=0), severity (mild=1, modret=2, sever =3) and site of pruritus (Face(trigeminal) =1, neuroaxial(dermatome)=2), 1,2,4, and 6 hours after operation. Incidence of pruritus total group incidence %. 3. The incidence of PONV.

NCT ID: NCT04018209 Recruiting - Clinical trials for Deciphering Aquagenic Pruritus in Myeloproliferaitive Neoplasms

Aquagenic Pruritus in Myeloproliferative Neoplasms

PANAM
Start date: July 9, 2019
Phase:
Study type: Observational

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms. Prospective work based on the distribution of a dedicated questionnaire.

NCT ID: NCT03808805 Recruiting - Clinical trials for Myeloproliferative Disorder

Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms

APHYPAP
Start date: April 16, 2019
Phase: Phase 3
Study type: Interventional

Phase 3, randomized prospective study, double blind-double placebo, testing oral therapies APREPITANT versus HYDROXYZINE in patients followed for myeloproliferative neoplasms and suffering of persistent aquagenic pruritus.

NCT ID: NCT03340155 Recruiting - Psoriasis Clinical Trials

Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases

BioUV2017
Start date: October 30, 2017
Phase: N/A
Study type: Interventional

The molecular mechanisms of action of photo(chemo)therapy in skin diseases are investigated in this study. The phototherapeutic modalities employed include UVB (ultraviolet B), UVA (ultraviolet A), PUVA (psoralen+UVA) and/or extracorporeal photochemotherapy (photopheresis). The study will address whether and how photo(chemo)therapy affects specific biologic pathways in different skin disorders and search for predictive biomarkers.

NCT ID: NCT03178058 Recruiting - Clinical trials for Postoperative Nausea and Vomiting

Risk Factors for Postoperative Nausea, Vomiting and Pruritus

Start date: October 2016
Phase: N/A
Study type: Observational

In this study we would like to identify demographic and individual risk factors that place parturients at a higher risk for postoperative nausea and vomiting (PONV) and itching following administered neuraxial morphine for cesarean section. Our primary objective is to develop a reliable predictive neuraxial morphine induced nausea and vomiting (NMINV) and itching model.

NCT ID: NCT03132142 Recruiting - Pain Clinical Trials

Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol

Start date: April 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the potential desensitising effects of repeated applications of capsaicin, trans-cinnamaldehyde and L-menthol on thermal, mechanical and chemical sensory stimulations.

NCT ID: NCT02432508 Recruiting - Clinical trials for Kidney Failure, Chronic

Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Start date: October 2014
Phase: N/A
Study type: Interventional

Uremic pruritus is a clinically significant symptom which imposes heavy impact on the quality of life of patients with chronic kidney disease undergoing hemodialysis. In order to investigate the clinical efficacy and mechanism, the investigators designed a multiple centers, randomized, assessor- and participant-blind, controlled, cross-over clinical trial. This trial will be conducted at Taichung branch, Feng-yuan branch and the Eastern branch of CMUH.

NCT ID: NCT01769144 Recruiting - Pain Clinical Trials

Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh

Start date: January 2013
Phase: N/A
Study type: Interventional

This study aims to compare the effectiveness of two wound dressings, Acticoat Absorbent (AA) and BCT Antimicrobial (BCT) on Split Thickness Skin Graft (STSG) donor site.